Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
![]() |
797 Real-world treatment duration of atezolizumab+carboplatin+etoposide among older patients with extensive-stage small cell lung cancer (ES-SCLC) and the impact of performance status and brain metastasesAlbarmawi, Husam ; Robinson, Scott ; Dietz, Kevin ; Norris, Kris ; Paranthaman, Nindhana ; Ogale, Sarika ; Schwartz, TaylorJournal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A830-A830 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
2 |
Material Type: Ata de Congresso
|
![]() |
Weekly Etoposide and Platinum in Small-Cell Lung Cancer: Hope and Scope for Fragile PatientsSundriyal, Deepak ; Kumar, Parmod ; Gogisetti, Yeswanth ; Sehrawat, AmitIndian Journal of Medical and Paediatric Oncology, 2021, Vol.42 (2) [Periódico revisado por pares]A-12, 2nd Floor, Sector 2, Noida-201301 UP, India: Thieme Medical and Scientific Publishers Pvt. LtdTexto completo disponível |
3 |
Material Type: Ata de Congresso
|
![]() |
Effect of Etoposide Treatment on ERG Transfected H358 Cell LineEmine Kandemiş ; Sara Alkhatib ; Barış Sergi ; Gülay BulutProceedings, 2018, Vol.2 (25), p.1589 [Periódico revisado por pares]MDPI AGTexto completo disponível |
4 |
Material Type: Ata de Congresso
|
![]() |
The ABC-study: A randomized phase III study comparing one course of adjuvant bleomycin, etoposide, and cisplatin (BEP) and one course of carboplatin AUC7 in clinical stage I seminomatous testicular cancerTandstad, Torgrim ; Stahl, Olof ; Dahl, Olav ; Glimelius, Ingrid ; Haugnes, Hege Sagstuen ; Karlsdottir, Asa ; Langberg, Carl Wilhelm ; Soderstrom, Karin ; Solberg, Arne ; Stierner, Ulrika K. ; Wall, Najme ; Cohn-Cedermark, Gabriella ElisabethJOURNAL OF CLINICAL ONCOLOGY, 2017, Vol.35 (15_suppl), p.TPS4593-TPS4593 [Periódico revisado por pares]Texto completo disponível |
5 |
Material Type: Ata de Congresso
|
![]() |
Durvalumab+ Tremelimumab + Platin-Etoposide in first-line extensive-stage SCLC (ES-SCLC): 36-month Overall Survival from the Phase 3 CASPIAN studyBischoff, H ; Paz-Ares, L ; Chen, Y ; Reinmuth, N ; Hotta, K ; Trukhin, D ; Statsenko, G ; Hochmair, M J ; Özgüroğlu, M ; Li, J H ; Voitko, O ; Poltoratskiy, A ; Verderame, F ; Havel, L ; Bondarenko, I ; Losonczy, G ; Conev, N ; Broadhurst, H ; Dalvi, T ; Jiang, H ; Golgman, J W ; Alt, JPneumologie, 2022, Vol.76 (S 01) [Periódico revisado por pares]Rüdigerstraße 14, 70469 Stuttgart, Germany: Georg Thieme VerlagTexto completo disponível |
6 |
Material Type: Ata de Congresso
|
![]() |
Analysis of stably expressed genes with low-dose etoposide for toxicological studies in osteosarcomaFerreira de Oliveira, JMP ; Almeida, L ; Pimentel, F ; Van Zoelen, EJJ ; Santos, CPlanta Medica, 2014, Vol.80 (16) [Periódico revisado por pares]Texto completo disponível |
7 |
Material Type: Ata de Congresso
|
![]() |
AB1481 EMERALD STUDY DESIGN: A TWO-COHORT, OPEN-LABEL, SINGLE-ARM STUDY OF EMAPALUMAB, AN ANTI–INTERFERON-Γ (IFNΓ) MONOCLONAL ANTIBODY, IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) IN RHEUMATIC DISEASESDe Benedetti, F ; Krmar, R ; Kanceva, R ; Grom, AAnnals of the rheumatic diseases, 2023, Vol.82 (Suppl 1), p.1969-1970 [Periódico revisado por pares]London: BMJ Publishing Group LTDTexto completo disponível |
8 |
Material Type: Ata de Congresso
|
![]() |
Cytotoxic effects of ethyl acetate extract of Sambucus ebulus compared with Etoposide on normal and cancer cell linesSaeedi Saravi, SS ; Shokrzadeh, M ; Mirzayi, MPlanta Medica, 2009, Vol.75 (9) [Periódico revisado por pares]Texto completo disponível |
9 |
Material Type: Ata de Congresso
|
![]() |
An integrated analysis of genome-wide DNA methylation and genetic variants underlying etoposide-induced cytotoxicity in European and African populationsLi, Ruowang ; Kim, Dokyoon ; Dudek, Scott M. ; Ritchie, Marylyn D. Esparcia-Alcázar, Anna I. ; Mora, Antonio M.Applications of Evolutionary Computation, p.928-938 [Periódico revisado por pares]Berlin, Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
10 |
Material Type: Ata de Congresso
|
![]() |
Phase II Studie zur simultanen Radiochemotherapie mit Cisplatin/Etoposide gefolgt von einer Erhaltungschemotherapie mit Platin/Gemcitabine bei nicht-resektablem nicht-kleinzelligem Bronchialkarzinom (NSCLC)Fink, T ; Melzner, W ; Strnad, V ; Sauer, R ; Birkenhake, S ; Ficker, JPneumologie, 2006, Vol.60 (S 1) [Periódico revisado por pares]Texto completo disponível |